Despite evolving infrastructure for alternative cosmetic testing in China, the regulatory climate remains hazy, according to L’Oreal SA, which recently obtained a license to market Episkin reconstructed skin models in the country for testing substances without the use of animals.
“Today there are no regulatory alternative methods accepted in China,” a L’Oreal rep said
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?